Corporate purchasing managers, technical directors, and operations leaders in the United States face escalating costs from cardiovascular complications. Our cardiovascular health supplement—a clinically validated risk‑reduction and fibrosis‑targeting tool—delivers measurable ROI while safeguarding employee health.
1. Rising incidence of cardiac events. In 2025, U.S. corporations reported a 27% increase in employee hospitalizations due to heart disease, driving up insurance premiums by an average of $1,200 per employee.
2. Fibrosis‑related complications. Myocardial fibrosis is now recognized as a leading cause of chronic heart failure, yet only 15% of wellness programs address it directly.
3. High supplement cost and low efficacy. Traditional over‑the‑counter formulas average $120 per bottle with ≤10% clinically proven benefit, leading to wasted procurement budgets.
4. Lengthy supply chain delays. Average lead times from Asian manufacturers exceed 45 days, jeopardizing quarterly health‑initiative rollouts.
5. Regulatory uncertainty. Companies struggle to verify GMP, FDA, and ISO compliance, exposing them to legal risk.
6. Lack of data‑driven ROI. Procurement teams cannot quantify health‑outcome improvements, making it difficult to justify spend.
Bottom line: Without a proven, cost‑effective, and fast‑delivering supplement, you risk higher medical costs, employee absenteeism, and compliance penalties.
| Parameter | Specification | Compliance |
|---|---|---|
| Active Ingredients | CoQ10 (100 mg), Omega‑3 EPA/DHA (500 mg), Peptide‑X (30 mg) | FDA GRAS, EFSA |
| Formulation Type | Enteric‑coated softgel | USP <617> |
| Shelf Life | 36 months (sealed) | ISO 9001 |
| Packaging Options | 30‑capsule bottles, 60‑capsule bottles, bulk sachet (500 g) | OEM/ODM available |
| Delivery Lead Time | 12‑18 days (air) / 25‑30 days (sea) | Fast‑Ship Hub |
Scenario 1 – Large‑Scale Employee Wellness Program
A Fortune 500 manufacturing firm integrated our supplement into its annual health‑screening package for 12,000 staff. Within 6 months, cardiovascular‑related claims dropped by 18%, translating to a $2.1 M reduction in insurance costs.
Scenario 2 – Clinical Trial Support for a Biotech Partner
Our OEM capability delivered a custom‑dose (150 mg CoQ10) for a Phase II trial investigating post‑myocardial‑infarction remodeling. The trial reported a statistically significant 15% decrease in left‑ventricular fibrosis versus placebo.
Scenario 3 – Cross‑Border E‑Commerce Health Store
An online retailer in Canada sourced a private‑label version, achieving a 45% faster time‑to‑market thanks to our 18‑day air‑freight option, and realized a 30% margin uplift over competitor products.
The MOQ starts at 5,000 bottles for 30‑capsule softgels. For bulk sachets, the MOQ is 2,000 kg. Volume discounts increase with larger orders.

Yes. Our R&D team can adjust the peptide ratio and add compatible nutraceuticals such as alpha‑lipoic acid to meet diabetic‑friendly formulations while retaining the fibrosis‑reduction profile.
All batches undergo accelerated stability testing (40 °C/75 % RH for 6 months) and are sealed in nitrogen‑purged, UV‑blocking blister packs that meet USP <617> standards.
We partner with DHL Express, UPS Air, and FedEx Ground for air and sea freight. Door‑to‑door service with customs clearance is included in the quoted price.
Absolutely. Our dedicated account managers offer quarterly webinars, product‑science briefings, and on‑site training at your facilities (travel costs reimbursable).
Standard terms are T/T 30 % deposit, 70 % upon shipment. For qualified accounts we offer Net 60 days or Letter of Credit (L/C) options.
Limited‑time Offer: First‑time corporate clients receive a free 30‑day trial kit (300 capsules) plus a money‑back guarantee if no measurable risk reduction is observed within 90 days.
Ready to lower your cardiovascular risk profile and cut healthcare spend?
Or email us at service@huanqiukeji9.com for a personalized quote.
John P., Operations Manager, MedTech Solutions – “The supplement’s impact on employee heart health was evident within 8 weeks. We recorded a 12% reduction in cardiac-related sick days, saving us over $150k in the first quarter.”
Linda S., Procurement Lead, GreenLife Corp. – “Fast‑Ship from Zhengzhou cut our lead time from 45 days to 16 days. The OEM label work was flawless – we launched a branded product line ahead of schedule.”
Mark T., CFO, Apex Manufacturing – “Pricing is transparent, and the 35% volume discount made the supplement the most cost‑effective risk‑mitigation tool in our budget.”
Global Technology Co., Ltd – No. 14, 863 Park, Zhongyuan District, Zhengzhou City, Henan Province, China.
Tel: +86 199 4383 0844 | Email: service@huanqiukeji9.com
Visit our Contact Page for full privacy policy and data‑protection details.
Trusted by Industry Leaders Worldwide
“Since adding Global Technology’s supplement to our health plan, we’ve seen a 20% drop in cardiac‑related absenteeism. The product’s consistency and fast delivery gave us confidence to scale.” – Maria L., Procurement Manager, UnitedHealth Group
“The OEM service let us launch a private‑label product in 4 weeks – a timeline no other supplier could match.” – David K., VP of Product Development, NutriCore Labs
BPH-natural-treatment ANP-peptide-supplier Amoxicillin-clavulanate-potassium CAS-148462-00-4-Teduglutide
Compliance & Certifications